Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exiting the outside world for cross-presentation.

Kenneth L Rock1

  • 1Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.

Immunity
|October 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A broad cathepsin inhibitor blocks crystal-stimulated inflammasome-dependent and -independent inflammation and gout arthritis.

Communications medicine·2026
Same author

Author Correction: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Nature immunology·2026
Same author

Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of β2M or TAP.

Cancer immunology research·2024
Same author

GENETIC ABLATION OF THE C-TYPE LECTIN RECEPTOR CLEC2D INCREASES PERITONITIS MORTALITY, INFLAMMATION, AND PHYSIOLOGY WITHOUT DIMINISHING ORGAN INJURY.

Shock (Augusta, Ga.)·2024
Same author

Tumor immune evasion through loss of MHC class-I antigen presentation.

Current opinion in immunology·2023
Same author

Pathways of MHC I cross-presentation of exogenous antigens.

Seminars in immunology·2023
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
Same journal

Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition.

Immunity·2026
Same journal

The transcription factor Eomes drives a stemness program in CD4<sup>+</sup> T cells that promotes anti-tumor immunity in response to immunotherapy.

Immunity·2026
Same journal

Stem-like precursors of exhausted Th cells upheld by a Tox-Myb-Eomes transcriptional hierarchy propagate Th cell responses in chronic infection.

Immunity·2026
Same journal

Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes.

Immunity·2026
See all related articles

Extracellular proteins are cross-presented on MHC class I via the ER-associated degradation (ERAD) export pathway operating in dendritic cell phagosomes. This pathway transfers antigens, enabling immune recognition.

Area of Science:

  • Immunology
  • Cell Biology
  • Protein Degradation

Background:

  • MHC class I molecules typically present endogenous antigens.
  • Cross-presentation of exogenous antigens on MHC class I is crucial for initiating adaptive immune responses.
  • The precise mechanisms for delivering extracellular antigens into the MHC class I pathway remain incompletely understood.

Discussion:

  • This study reveals that the ER-associated degradation (ERAD) export pathway is functional within phagosomes of dendritic cells.
  • The ERAD machinery facilitates the transfer of phagosomal antigens into the MHC class I presentation pathway.
  • This finding challenges previous models that localized ERAD exclusively to the endoplasmic reticulum.

Key Insights:

  • The ER-associated degradation (ERAD) export pathway plays a direct role in the cross-presentation of extracellular antigens on MHC class I molecules.

Related Experiment Videos

  • Antigen transfer from phagosomes to the MHC class I pathway is mediated by the ERAD machinery.
  • Dendritic cells utilize ERAD within phagosomes to process and present exogenous antigens.

    • Outlook:

    • Further investigation into the specific components and regulation of phagosomal ERAD is warranted.
    • Understanding this pathway could lead to novel strategies for cancer immunotherapy and vaccine development.
    • Exploring the broader implications of ERAD in other antigen-presenting cells may reveal new immunological insights.